Sunrest Lifescience IPO will open for subscription from 07 November 2023. The company aims for an issue size of ₹10.85 Cr through this IPO.
Company Overview
| Full name | Sunrest Lifescience Limited |
| Sector | Trading |
| Industry | Trading |
| Company Website | https://sunrestlifescience.com/ |
About Company
The company is engaged in the marketing of OTC generic pharmaceutical products in the domestic market. Sunrest Lifescience offers a range of pharmaceutical products manufactured by third-party manufacturers. It operates in different states of India including Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan. The company has a presence in these states through trademarks registered products and/or products under registration.
Sunrest Lifescience deals in Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Its product portfolio comprises of wide range of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Material, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The company has 18 registered trademarks for 32 products.
Its business operations are supported by one of its group companies and various third-party manufacturers. Sunrest Lifescience typically works on a third-party manufacturing basis or at times purchase order basis with the manufacturer of pharma products, depending upon the customer’s requirement.
The Objectives of the Issue
Sunrest Lifescience IPO Timetable
| IPO Opening date | 07 November 2023 |
| IPO Closing | 09 November 2023 |
| Basis of Allotment | 15 November 2023 |
| Initiation Refund | 16 November 2023 |
| Credit to Demat Account | 17 November 2023 |
| Listing Date | 20 November 2023 |
Sunrest Lifescience IPO details
| Issue type | Fixed Price Issue IPO |
| IPO issue size | ₹10.85 Cr – 1,291,200 shares |
| Fresh Issue | ₹10.85 Cr – 1,291,200 shares |
| Offer for sale | Nil |
| Face value | ₹10 per share |
| Offer Price | ₹84 per share |
| Lot size | 1600 Shares |
| Market Maker portion | 65,600 shares |
| Shareholding pre-issue | 3,000,000 |
| Shareholding post-issue | 4,291,200 |
| Listing Exchange | NSE SME |
Sunrest Lifescience IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹134,400 |
| Retail (Max) | 1 | 1600 | ₹134,400 |
| HNI (Min) | 2 | 3,200 | ₹268,800 |
Sunrest Lifescience IPO Reservation Details
| Retail Shares Offered | 50% |
| Other Shares Offered | 50% |
Sunrest Lifescience Financial Performance
| FY 2021 | FY 2022 | FY 2023 | Q1 FY 2024 | |
| Revenue | 16.95 | 26.89 | 24.64 | 5.64 |
| Expenses | 16.72 | 25.86 | 21.93 | 4.66 |
| Net income | 0.17 | 0.78 | 2.04 | 0.75 |
Sunrest Lifescience Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 0.55 | 2.59 | 6.81 |
| PE ratio | – | – | 12.33 |
| RONW (%) | 56.12 | 72.49 | 65.59 |
| NAV | – | – | 10.38 |
| EBITDA (%) | 1.62 | 4.17 | 11.89 |
| Debt/Equity | 7.72 | 2.88 | 0.64 |
Company Promoters
- Mr. Nikhilkumar Y Thakkar
- Mr. Amitbhai Shambhulal Thakkar
- Mr. Bhagyesh Kiritbhai Parekh
- Mr. Bharatkumar V Thakkar.
Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 69.91% |
Sunrest Lifescience IPO Lead Manager(s)
MARK CORPORATE ADVISORS PRIVATE LIMITED
404/1, The Summit Business Bay,
Sant Janabai Road (Service Lane), Off W. E. Highway,
Vile Parle (East), Mumbai-400 057, Maharashtra
Phone: +91 22 2612 3208
Email: smeipo@markcorporateadvisors.com
Website: www.markcorporateadvisors.com
Sunrest Lifescience IPO Registrar
SKYLINE FINANCIAL SERVICES PRIVATE LIMITED
D-153A, First Floor, Okhla Industrial Area,
Phase-I, New Delhi, 110020
Phone: 011 26812682
Email: grievances@skylinerta.com
Website: www.skylinerta.com
Sunrest Lifescience Contact Details
SUNREST LIFESCIENCE LIMITED
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar Bus Stand,
Vastral Road, Ahmedabad-382415, Gujarat
Phone: 079 – 29918245
E-mail: info@sunrestlifescience.com
Website: www.sunrestlifescience.com
Sunrest Lifescience IPO Allotment Status
Sunrest Lifescience IPO allotment status will be available on Skyline Financial Services’ website. Click on this link to get allotment status.
Final thoughts
Sunrest Lifescience IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. study well about the company and subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.
Happy Investing
